In the media
News
Partner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyIn the media
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Read full storyPartner news
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
Read full storyPartner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyIn the media
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
Read full storyIn the media
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyIn the media
Ethics should be a compulsory course for every science student
Read full storyIn the media
Women Who Tech Launches Health Innovation Challenge
Read full storyPartner news
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Read full storyJNJ Press releases
Janssen Announces Collaboration with UC Berkeley, UCSF to Expand Data Science Research in Healthcare
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news